Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
about
Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic AscitesCCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy.Simple patterned nanofiber scaffolds and its enhanced performance in immunoassay.Production and characterization of a peptide-based monoclonal antibody against CD44 variant 6.Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients.The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
P2860
Q26852899-E977127D-26DC-435A-99CD-1295B814C9C8Q33925682-FC670A6A-1F14-4B99-B3C8-986811EA339AQ34204891-040BFA95-23C8-47C9-BFAA-B739B40EB0A1Q35067899-34CFABF7-5752-4704-851E-94E887D98B2AQ35149333-FBA18D2D-2803-4FE2-991E-EAFEBA9C3FA6Q35954103-97D3B99E-45CB-4A49-AA1B-FA9343643F53Q36474315-4BE2C784-C651-4A74-90E4-F7F34EC003A0Q37041074-4949D02A-FD0A-469F-B60D-E6B0E0D0AB4CQ37564029-0B2869E8-9168-4DD9-8B22-27F2B2295ACFQ39244996-FE62CD90-E49B-48A4-9A99-04D3D6ECB61D
P2860
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@ast
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@en
type
label
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@ast
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@en
prefLabel
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@ast
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@en
P2093
P2860
P1476
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
@en
P2093
Bao-Ping Yu
He-Sheng Luo
Jie-Ping Yu
Wei-Guo Dong
Xiao-Min Sun
P2860
P304
P407
P577
2003-11-01T00:00:00Z